PET Scan in Lung Cancer: Current Recommendations and Innovation
- 1 January 2006
- journal article
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 1 (1), 71-73
- https://doi.org/10.1097/01243894-200601000-00014
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Meta-Analysis of Positron Emission Tomographic and Computed Tomographic Imaging in Detecting Mediastinal Lymph Node Metastases in Nonsmall Cell Lung CancerThe Annals of Thoracic Surgery, 2005
- Nodules, CT-scans and PET-scans: a good partnershipLung Cancer, 2004
- Test Performance of Positron Emission Tomography and Computed Tomography for Mediastinal Staging in Patients with Non–Small-Cell Lung CancerAnnals of Internal Medicine, 2003
- Mediastinal lymph node staging in suspected lung cancer: comparison of positron emission tomography with F-18-fluorodeoxyglucose and mediastinoscopyThe Annals of Thoracic Surgery, 2003
- Noninvasive Staging of Non-small Cell Lung Cancer*Chest, 2003
- Positron emission tomography in the diagnosis and staging of lung cancer: a systematic, quantitative reviewThe Lancet Oncology, 2001
- Metaanalyse zum Stellenwert der Positronen-Emissions-Tomographie mit F-18-Fluorodesoxyglukose (FDG-PET) bei Lungentumoren1 - Diskussionsbasis der deutschen Konsensus-Konferenz Onko-PET 2000 -Pneumologie, 2001
- The role of positron emission tomography with 18 F-fluoro-2-deoxy-D-glucose in respiratory oncologyEuropean Respiratory Journal, 2001
- Metastases from Non-Small Cell Lung Cancer: Mediastinal Staging in the 1990s—Meta-analytic Comparison Of PET and CTRadiology, 1999
- Mediastinal Lymph Node Staging With FDG-PET Scan in Patients With Potentially Operable Non-small Cell Lung CancerChest, 1997